<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The der(16)t(1;16)(q11;q11) is a frequent recurrent rearrangement in <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumours</z:e> such as <z:hpo ids='HP_0003002'>breast carcinomas</z:hpo> and Ewings <z:hpo ids='HP_0100242'>sarcomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, this abnormality was described also in <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We identified a der(16)t(1;16)(q11;q11) in three patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, either during preleukaemic phase (n = 2) or at the time of blastic transformation (n = 1) </plain></SENT>
<SENT sid="3" pm="."><plain>Breakpoints were ascertained by fluorescence in situ hybridization (FISH) using specific centromeric alpha-satellite probes and whole chromosome painting for chromosome 1 and chromosome 16 </plain></SENT>
<SENT sid="4" pm="."><plain>These observations, combined with <z:hpo ids='HP_0003745'>isolated cases</z:hpo> of the literature, suggest that der(16)t(1;16)(q11; q11) is a nonrandom abnormality associated with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
</text></document>